News

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer ...
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
PRN02047 To: integrated care boards – chief executives GP practices community pharmacies primary care networks NHS trusts – chief executives local government chief executives health and justice ...